080720.KQ
Union Korea Pharm Co Ltd
Price:  
2,725 
KRW
Volume:  
255,136
Korea, Republic of | Pharmaceuticals

080720.KQ WACC - Weighted Average Cost of Capital

The WACC of Union Korea Pharm Co Ltd (080720.KQ) is 5.4%.

The Cost of Equity of Union Korea Pharm Co Ltd (080720.KQ) is 7.6%.
The Cost of Debt of Union Korea Pharm Co Ltd (080720.KQ) is 5.5%.

RangeSelected
Cost of equity6.5% - 8.7%7.6%
Tax rate23.1% - 24.4%23.75%
Cost of debt4.0% - 7.0%5.5%
WACC4.3% - 6.6%5.4%
WACC

080720.KQ WACC calculation

CategoryLowHigh
Long-term bond rate3.1%3.6%
Equity market risk premium5.8%6.8%
Adjusted beta0.590.68
Additional risk adjustments0.0%0.5%
Cost of equity6.5%8.7%
Tax rate23.1%24.4%
Debt/Equity ratio
1.721.72
Cost of debt4.0%7.0%
After-tax WACC4.3%6.6%
Selected WACC5.4%

080720.KQ's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 080720.KQ:

cost_of_equity (7.60%) = risk_free_rate (3.35%) + equity_risk_premium (6.30%) * adjusted_beta (0.59) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.